Proper drug margin is essential for pharmaceutical industry

In a brief session with IFPMA Chairman Dr. Harvey E. Bale Jr., who visited the Korea Pharmaceutical Manufacturers Association on November 13, the association's chairman Kim Chung-soo and president Rhee Jang-han (chairman of Chong Kun Dang Pharmaceuticals) shared their opinions on the issue that in situation where pharmaceutical firms are in the position to secure their proper drug margin in mar...